# BMP2

## Overview
Bone morphogenetic protein 2 (BMP2) is a gene that encodes a member of the transforming growth factor-beta (TGF-β) superfamily, specifically the protein bone morphogenetic protein 2. This protein is a critical regulator of bone and cartilage development, playing a pivotal role in the differentiation of mesenchymal cells into osteoblasts, which are essential for bone formation and repair (Balint2003Phenotype; HughesFulford2011The). BMP2 functions through serine/threonine kinase receptors, activating SMAD proteins to mediate its effects on gene expression, particularly those involved in extracellular matrix development and mineralization (Balint2003Phenotype). The protein is characterized by a cystine-knot motif and forms a disulfide-linked homodimer, which is crucial for its stability and bioactivity (Halloran2020Bonea). Clinically, mutations and alterations in the BMP2 gene are associated with various conditions, including syndromic cleft palate and heterotopic ossification, highlighting its significance in skeletal development and maintenance (Sahoo2011Microdeletion; Prados2021Heterotopic).

## Structure
Bone morphogenetic protein 2 (BMP-2) is synthesized as a 453-residue proprotein, which includes a signal peptide, a pro-domain, and a mature peptide. The mature BMP-2 is a dimeric protein, with each monomer consisting of 114 amino acid residues (Huang2020Biomaterial-guided; Halloran2020Bonea). The protein's three-dimensional structure is described as a twisted banana-shaped molecule with dimensions of 70 Å × 35 Å × 30 Å (Huang2020Biomaterial-guided).

The secondary structure of BMP-2 includes two antiparallel β-sheets and a four-turn α-helix, which are crucial for its bioactivity and receptor binding (Marquetti2022An; Halloran2020Bonea). The tertiary structure is characterized by a cystine-knot motif formed by six cysteine residues creating three intrachain disulfide bridges, which are essential for the protein's stability (Huang2020Rotation-induced; Halloran2020Bonea). The quaternary structure involves the formation of a disulfide-linked homodimer, further stabilizing the protein by creating a hydrophobic core between the monomers (Halloran2020Bonea).

Post-translational modifications of BMP-2 include glycosylation, which is important for its proper folding and function (Halloran2020Bonea). BMP-2 can exist in different isoforms due to alternative splicing, contributing to its functional diversity (Huang2020Biomaterial-guided).

## Function
BMP2 (bone morphogenetic protein 2) is a critical regulator in the differentiation of mesenchymal cells into osteoblasts, which are essential for bone formation. It functions as a member of the TGF-beta superfamily and signals through serine/threonine kinase receptors, activating SMAD proteins to mediate its effects (Balint2003Phenotype). BMP2 plays a pivotal role in osteoblast differentiation by inducing the expression of genes involved in extracellular matrix (ECM) development, such as small leucine-rich proteoglycan (SLRP) genes, which are necessary for the phenotypic conversion to committed osteoblasts (Balint2003Phenotype).

In the cellular context, BMP2 influences gene expression patterns, promoting the upregulation of osteogenic markers like Runx2, alkaline phosphatase, and osteocalcin, while downregulating myogenic markers such as myogenin and MyoD. This shift from a myogenic to an osteogenic phenotype underscores BMP2's role in promoting bone cell differentiation (Balint2003Phenotype). BMP2 is also involved in the mineralization stage of bone repair, inducing genes like collagen type I and osteocalcin, which are crucial for bone ECM organization and mineralization (HughesFulford2011The).

Organismally, BMP2 is essential for skeletal development and maintenance, contributing to processes such as bone defect repair and the reversal of osteopenia (Balint2003Phenotype).

## Clinical Significance
Mutations and alterations in the BMP2 gene are associated with several clinical conditions. BMP2 haploinsufficiency has been linked to syndromic cleft palate, a birth defect characterized by a cleft in the roof of the mouth. Microdeletions at chromosome 20p12.3, which include the BMP2 gene, have been associated with orofacial clefts and facial dysmorphism, suggesting that BMP2 plays a critical role in craniofacial development (Sahoo2011Microdeletion).

Alterations in BMP2 expression are also implicated in bone-related disorders. Overexpression of BMP2 can lead to heterotopic ossification (HO), a condition where bone forms in soft tissues, as observed in transgenic mouse models. This overexpression is associated with skeletal deformities and conditions such as Fibrodysplasia Ossificans Progressiva (FOP) (Prados2021Heterotopic).

BMP2 mutations can also affect bone development and repair. A duplication of a regulatory element downstream of BMP2 is linked to brachydactyly type A2 (BDA2), characterized by hypoplasia of the second middle phalanx of the index finger (Wu2016TGF-β). BMP2 is essential for fracture healing, and its deficiency can lead to spontaneous fractures and impaired healing (Wang2014Bone).

## Interactions
BMP2 interacts with various receptors and molecules, playing a significant role in bone and cartilage development. It forms a 1:2 complex with the BMP receptor type IA (BMPR-IA), where one BMP2 molecule binds with two receptor molecules. This interaction is crucial for receptor activation and subsequent signaling pathways (Kirsch2000Isolation). The binding interface between BMP2 and BMPR-IA involves a series of hydrogen bonds, with a central hydrogen-bonding network that includes a significant interaction between BMP2 Leu51 and BRIA Gln86, identified as a binding hot spot (Keller2004Molecular).

BMP2 also interacts with type II receptors such as ActR-IIB, ActR-II, and BMPR-II. These interactions are characterized by hydrophobic interactions, with specific residues like Trp60 and Tyr42 of ActR-IIB playing significant roles in binding affinity (Weber2007A). The interaction with type II receptors involves a hetero-oligomeric complex formation, where the type II receptor transphosphorylates the type I receptor, activating the SMAD signaling pathways (Weber2007A).

BMP2 contains a heparin-binding site in its N-terminal region, which modulates its biological activity. This interaction affects BMP2's activity by limiting its diffusion and establishing morphogenetic gradients during development (Ruppert1996Human).


## References


[1. (Marquetti2022An) Izabele Marquetti and Salil Desai. An atomistic investigation of adsorption of bone morphogenetic protein-2 on gold with nanoscale topographies. Surfaces, 5(1):176–185, February 2022. URL: http://dx.doi.org/10.3390/surfaces5010010, doi:10.3390/surfaces5010010. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/surfaces5010010)

[2. (Huang2020Rotation-induced) Baolin Huang, Milan He, Ke Zhang, Suli Sun, Zuo Lin, Dafu Chen, Tong Li, and Xiaofeng Chen. Rotation-induced secondary structure losses and bioactivity changes of bone morphogenetic protein-2 on strontium-substituted hydroxyapatite surfaces. Applied Surface Science, 511:145623, May 2020. URL: http://dx.doi.org/10.1016/j.apsusc.2020.145623, doi:10.1016/j.apsusc.2020.145623. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.apsusc.2020.145623)

[3. (Keller2004Molecular) Sascha Keller, Joachim Nickel, Jin-Li Zhang, Walter Sebald, and Thomas D Mueller. Molecular recognition of bmp-2 and bmp receptor ia. Nature Structural &amp; Molecular Biology, 11(5):481–488, April 2004. URL: http://dx.doi.org/10.1038/nsmb756, doi:10.1038/nsmb756. This article has 252 citations.](https://doi.org/10.1038/nsmb756)

[4. (Wu2016TGF-β) Mengrui Wu, Guiqian Chen, and Yi-Ping Li. Tgf-β and bmp signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Research, April 2016. URL: http://dx.doi.org/10.1038/boneres.2016.9, doi:10.1038/boneres.2016.9. This article has 1485 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/boneres.2016.9)

[5. (Kirsch2000Isolation) Thomas Kirsch, Joachim Nickel, and Walter Sebald. Isolation of recombinant bmp receptor ia ectodomain and its 2:1 complex with bmp‐2. FEBS Letters, 468(2–3):215–219, February 2000. URL: http://dx.doi.org/10.1016/s0014-5793(00)01214-x, doi:10.1016/s0014-5793(00)01214-x. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-5793(00)01214-x)

[6. (Balint2003Phenotype) Eva Balint, David Lapointe, Hicham Drissi, Caroline van der Meijden, Daniel W. Young, Andre J. van Wijnen, Janet L. Stein, Gary S. Stein, and Jane B. Lian. Phenotype discovery by gene expression profiling: mapping of biological processes linked to bmp‐2‐mediated osteoblast differentiation. Journal of Cellular Biochemistry, 89(2):401–426, April 2003. URL: http://dx.doi.org/10.1002/jcb.10515, doi:10.1002/jcb.10515. This article has 137 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.10515)

[7. (HughesFulford2011The) Millie Hughes-Fulford and Chai-Fei Li. The role of fgf-2 and bmp-2 in regulation of gene induction, cell proliferation and mineralization. Journal of Orthopaedic Surgery and Research, 6(1):8, 2011. URL: http://dx.doi.org/10.1186/1749-799X-6-8, doi:10.1186/1749-799x-6-8. This article has 134 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1749-799X-6-8)

[8. (Prados2021Heterotopic) Belén Prados, Raquel del Toro, Donal MacGrogan, Paula Gómez-Apiñániz, Tania Papoutsi, Pura Muñoz-Cánoves, Simón Méndez-Ferrer, and José Luis de la Pompa. Heterotopic ossification in mice overexpressing bmp2 in tie2+ lineages. Cell Death &amp; Disease, July 2021. URL: http://dx.doi.org/10.1038/s41419-021-04003-0, doi:10.1038/s41419-021-04003-0. This article has 10 citations.](https://doi.org/10.1038/s41419-021-04003-0)

[9. (Sahoo2011Microdeletion) Trilochan Sahoo, Aaron Theisen, Pedro A. Sanchez‐Lara, Michael Marble, Daniela N. Schweitzer, Beth S. Torchia, Allen N. Lamb, Bassem A. Bejjani, Lisa G. Shaffer, and Yves Lacassie. Microdeletion 20p12.3 involving bmp2 contributes to syndromic forms of cleft palate. American Journal of Medical Genetics Part A, 155(7):1646–1653, June 2011. URL: http://dx.doi.org/10.1002/ajmg.a.34063, doi:10.1002/ajmg.a.34063. This article has 38 citations.](https://doi.org/10.1002/ajmg.a.34063)

[10. (Huang2020Biomaterial-guided) Baolin Huang, Yuan Yuan, and Changsheng Liu. Biomaterial-guided immobilization and osteoactivity of bone morphogenetic protein-2. Applied Materials Today, 19:100599, June 2020. URL: http://dx.doi.org/10.1016/j.apmt.2020.100599, doi:10.1016/j.apmt.2020.100599. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.apmt.2020.100599)

[11. (Halloran2020Bonea) Daniel Halloran, Hilary W. Durbano, and Anja Nohe. Bone morphogenetic protein-2 in development and bone homeostasis. Journal of Developmental Biology, 8(3):19, September 2020. URL: http://dx.doi.org/10.3390/jdb8030019, doi:10.3390/jdb8030019. This article has 149 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jdb8030019)

[12. (Weber2007A) Dionys Weber, Alexander Kotzsch, Joachim Nickel, Stefan Harth, Axel Seher, Uwe Mueller, Walter Sebald, and Thomas D Mueller. A silent h-bond can be mutationally activated for high-affinity interaction of bmp-2 and activin type iib receptor. BMC Structural Biology, February 2007. URL: http://dx.doi.org/10.1186/1472-6807-7-6, doi:10.1186/1472-6807-7-6. This article has 181 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1472-6807-7-6)

[13. (Ruppert1996Human) Rainer Ruppert, Elke Hoffmann, and Walter Sebald. Human bone morphogenetic protein 2 contains a heparin‐binding site which modifies its biological activity. European Journal of Biochemistry, 237(1):295–302, April 1996. URL: http://dx.doi.org/10.1111/j.1432-1033.1996.0295n.x, doi:10.1111/j.1432-1033.1996.0295n.x. This article has 458 citations.](https://doi.org/10.1111/j.1432-1033.1996.0295n.x)

[14. (Wang2014Bone) Richard N. Wang, Jordan Green, Zhongliang Wang, Youlin Deng, Min Qiao, Michael Peabody, Qian Zhang, Jixing Ye, Zhengjian Yan, Sahitya Denduluri, Olumuyiwa Idowu, Melissa Li, Christine Shen, Alan Hu, Rex C. Haydon, Richard Kang, James Mok, Michael J. Lee, Hue L. Luu, and Lewis L. Shi. Bone morphogenetic protein (bmp) signaling in development and human diseases. Genes &amp; Diseases, 1(1):87–105, September 2014. URL: http://dx.doi.org/10.1016/j.gendis.2014.07.005, doi:10.1016/j.gendis.2014.07.005. This article has 761 citations.](https://doi.org/10.1016/j.gendis.2014.07.005)